211 related articles for article (PubMed ID: 11471355)
1. There's still gold in them thar pills.
O'Reilly B
Fortune; 2001 Jul; 144(2):58-62, 66-8, 70. PubMed ID: 11471355
[No Abstract] [Full Text] [Related]
2. Can personalized drugs pay off?
Stipp D
Fortune; 2002 May; 145(10):168. PubMed ID: 12025349
[No Abstract] [Full Text] [Related]
3. Plans struggle for control of specialty pharma costs.
Carroll J
Manag Care; 2005 Sep; 14(9):41-2, 45-8. PubMed ID: 16238258
[No Abstract] [Full Text] [Related]
4. A new prescription for your portfolio.
Clifford L; O'Keefe B; Stires D
Fortune; 2001 Jul; 144(2):74-6, 78, 80. PubMed ID: 11471357
[No Abstract] [Full Text] [Related]
5. 'The future of cancer treatment'.
O'Keefe B
Fortune; 2001 Jul; 144(2):80. PubMed ID: 11471358
[No Abstract] [Full Text] [Related]
6. Biotechnology partnerships--medicine for an ailing industry?
DeLamarter J
Nat Biotechnol; 2003 Aug; 21(8):847-8. PubMed ID: 12894192
[No Abstract] [Full Text] [Related]
7. Rising costs hold up drug discovery.
Miller HI
Nature; 1998 Oct; 395(6705):835. PubMed ID: 9804407
[No Abstract] [Full Text] [Related]
8. Investment indicators show US is still ahead.
Lähteenmäki R; Hodgson J
Nat Biotechnol; 1998 Feb; 16(2):149-50. PubMed ID: 9487519
[No Abstract] [Full Text] [Related]
9. How the street sees biotech.
Lashinsky A
Fortune; 2003 Jun; 147(11):86. PubMed ID: 12800576
[No Abstract] [Full Text] [Related]
10. Genomic sciences and the medicine of tomorrow.
Drews J
Nat Biotechnol; 1996 Nov; 14(11):1516-8. PubMed ID: 9634812
[No Abstract] [Full Text] [Related]
11. Big pharma swallows biotech's pride.
Huggett B
Nat Biotechnol; 2008 Sep; 26(9):955-6. PubMed ID: 18779785
[No Abstract] [Full Text] [Related]
12. BIO 2006 Annual International Convention. The current state of the global biotechnology industry.
Zarkowska T
IDrugs; 2006 Jun; 9(6):381-2. PubMed ID: 16752301
[No Abstract] [Full Text] [Related]
13. Spinning the wheel on ImClone.
Varchaver N
Fortune; 2003 Apr; 147(8):123-5. PubMed ID: 12728651
[No Abstract] [Full Text] [Related]
14. Democracy unleashed--unpacking the tooth fairy in drug industry R&D.
Ozdemir V; Williams-Jones B
Nat Biotechnol; 2006 Nov; 24(11):1324-6; author reply 1326-7. PubMed ID: 17093467
[No Abstract] [Full Text] [Related]
15. Eli Lilly enters venture capital arena.
Fletcher L
Nat Biotechnol; 2001 Nov; 19(11):997-8. PubMed ID: 11689830
[No Abstract] [Full Text] [Related]
16. Any diamonds in the diagnostic coal?
Jacobs T
Nat Biotechnol; 2006 Aug; 24(8):930. PubMed ID: 16900133
[No Abstract] [Full Text] [Related]
17. Bugs or drugs, tortoises or hares?
Jacobs T
Nat Biotechnol; 2005 Mar; 23(3):293. PubMed ID: 15765079
[No Abstract] [Full Text] [Related]
18. Plenty of green in gray market. There's more at issue than just inflated prices for drugs in short supply.
May D
Mod Healthc; 2011 Oct; 41(42):25. PubMed ID: 22049782
[No Abstract] [Full Text] [Related]
19. The stampede to convertibles.
Jacobs T
Nat Biotechnol; 2003 Aug; 21(8):855. PubMed ID: 12894195
[No Abstract] [Full Text] [Related]
20. Biotech's billion dollar breakthrough.
Stipp D
Fortune; 2003 May; 147(10):96-8, 100, 103. PubMed ID: 12776500
[No Abstract] [Full Text] [Related]
[Next] [New Search]
